New eye drops aim to stop allergy itch and redness
NCT ID NCT07220408
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests a new eye drop called TL-925 for seasonal allergic conjunctivitis (eye allergies). About 60 adults with a history of eye allergies will receive either the active eye drop or a placebo. Researchers will measure how well it reduces itching and redness after exposure to allergens.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- TL-925 eye drops
- What this could lead to
- If it works, this could provide a new treatment option for eye allergies, reducing itching and redness.
- What could go wrong
- This is an early Phase 2 study with only 60 people, so results may not apply to everyone. The eye drops may not work better than placebo.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALLERGIC CONJUNCTIVITIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Advancing Vision Research
RECRUITINGSmyrna, Tennessee, 37167, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Experimental antibodies aim to block cat allergy eye itch
- Eye insert could ease allergy symptoms for contact lens wearers
- New eye drops zap allergy itch in just minutes
- Which eye drop stings less? small study pits flarex against lotemax SM
- Scientists hunt for eye disease clues in your tears
- Can ectoin sprays and drops soothe hay fever? new study investigates